Market›Health Care›Life Sciences Tools & Services›Life Sciences Tools & Services
WUXI BIOLOGICS CAYMA

WXIBF

$4.70Apr 26, 2021 – Apr 24, 2026
Health CareLife Sciences Tools & Services$19.01B
MVM
+$19.01B
TD Variance
0.130

Every news event mapped to its market reaction — 46 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2024-09-27+37.0%newsSeeking AlphaWuXi Biologics: Consider Proposed Legislation And Financial Prospects
2022-02-08-21.7%newsSeeking AlphaChinese biotechs lower after WuXi Biologics added to U.S. unverified list
2021-08-23+14.7%newsSeeking AlphaWuxi Biologics ADR reports 1H results
2024-12-20+12.7%newsSeeking AlphaAadi Bioscience rockets 72% on key updates
2024-08-22-12.4%earningsSeeking AlphaWuXi Biologics (Cayman) Inc. (WXXWY) Q2 2024 Earnings Call Transcript
2024-08-22-12.4%earningsSeeking AlphaWuXi Biologics (Cayman) Inc. 2024 Q2 - Results - Earnings Call Presentation
2022-05-30+8.0%earningsSeeking AlphaHarding Loevner - WuXi Biologics: Sporting A 100x Forward Price-To-Earnings Multiple
2024-01-19-7.8%newsSeeking AlphaWuXi Biologics: Recent Share Price Recovery Isn't Sustainable
2026-03-26+3.5%earningsSeeking AlphaWuXi Biologics (Cayman) Inc. 2025 Q4 - Results - Earnings Call Presentation
2026-03-26+3.5%earningsSeeking AlphaWuXi Biologics (Cayman) Inc. (WXXWY) Q4 2025 Earnings Call Transcript
2026-03-26+3.5%earningsSeeking AlphaWuXi Biologics (Cayman) Inc. 2025 Q4 - Results - Earnings Call Presentation (OTCMKTS:WXXWY) 2026-03-26 - Seeking Alpha
2026-03-30-2.6%legalPR NewswireWuXi Biologics Honored with CDMO Leadership Awards for Ninth Consecutive Year
2022-10-12-2.3%newsSeeking AlphaWuXi, Toregem team up to develop potential tooth regeneration therapy TRG035
2026-01-16+2.1%newsYahoo FinanceIs WuXi Biologics (SEHK:2269) Still Attractively Priced After Its 121% One Year Rebound - Yahoo Finance
2026-03-27+2.0%legalThe Globe and MailWuxi Biologics (Cayman) (WXIBF) Receives a Hold from Bank of America Securities - The Globe and Mail
2026-04-23+1.8%newsPR NewswireWuXi Biologics Receives South Korea MFDS GMP Certification to Enable Commercial Manufacturing of Bispecific Antibody Therapeutics
2023-07-19-1.7%newsSeeking AlphaWuXi Biologics Hatches New Baby With ADC Drug Unit IPO
2026-02-11+1.6%earningsThe Globe and MailWuXi Biologics Forecasts Strong 2025 Profit Growth on Expanded Services and Efficiency Gains - The Globe and Mail
2025-01-21-1.5%analystSeeking AlphaWuXi Biologics: Spotlight On Property Disposal And Operating Metrics (Rating Upgrade)
2022-10-10+1.4%newsSeeking AlphaWuxi Biologics gets off U.S. 'unverified' trade list
2026-02-03+1.3%newsRTTNewsWuXi Biologics Jumps On Pact With Vertex Pharma For T-Cell Engager In Autoimmune Disease - RTTNews
2026-03-16-1.3%M&ASimply Wall St.WuXi Biologics Awards Win And Earendil Deal Viewed Against Valuation
2026-03-25+1.2%newsPR NewswireWuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture
2026-03-25+1.2%newsThe Globe and MailWuXi Biologics Schedules Briefings on 2025 Annual Results for Global Investors - The Globe and Mail
2024-03-14+1.2%newsSeeking AlphaBiotech group backs anti-China bill; part ways with WuXi AppTec
2023-01-05-1.1%newsSeeking AlphaGSK inks licensing pact with WuXi Biologics for T cell engagers
2026-03-22-1.1%newsPR NewswireWorld Water Day: WuXi Biologics Advances Water Stewardship and Achieves Water Target
2026-04-15-1.0%newsPR NewswireWuXi Biologics Achieves ISO 13485 Certification, Signifying Strong Capabilities in Drug-Device Combination Product Development and Manufacturing
2026-04-17-1.0%newsPR NewswireWuXi Biologics Recognized by Morningstar Sustainalytics as Industry and Regional ESG Leader for Sixth Year
2026-04-17-1.0%newsSeeking AlphaWuXi Biologics Recognized by Morningstar Sustainalytics as Industry and Regional ESG Leader for Sixth Year - Seeking Alpha
2022-11-21-1.0%expansionSeeking AlphaWuXi Biologics launches new center in Shanghai to boost drug manufacturing capacity
2024-07-16+0.8%newsSeeking AlphaThe Good And The Bad For WuXi Biologics
2024-02-08-0.6%newsSeeking AlphaPotential U.S. Targeting Casts Shadow Over WuXi AppTec Family
2025-01-06+0.6%newsSeeking AlphaMerck to buy vaccine plant from WuXi Biologics: report
2026-04-06-0.5%newsSeeking AlphaAkari Therapeutics slides 21% despite WuXi XDC backing its drug program
2026-04-09-0.5%newsSimply Wall St.Assessing WuXi Biologics (SEHK:2269) Valuation After Choppy Returns And An Undervalued Narrative
2023-05-08+0.4%analystSeeking AlphaWuXi Biologics: Room For Valuation De-Rating (Rating Downgrade)
2023-06-01+0.2%newsSeeking AlphaWuXi Biologics to boost manufacturing capacity in Germany
2026-01-14+0.2%newsSeeking AlphaWuXi Biologics (Cayman) Inc. (WXXWY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
2026-01-14+0.2%newsSeeking AlphaWuXi Biologics (Cayman) Inc. (WXXWY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
2026-03-24-0.2%newsPR NewswireWuXi Biologics Reports Record 2025 Annual Results
2026-03-24-0.2%earningsSeeking AlphaWuxi Biologics Non-GAAP EPS of 1.33, revenue of 21.79M
2026-01-15-0.2%newsSeeking AlphaWuXi Biologics (Cayman) Inc. (WXXWY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
2025-05-18-0.1%analystSeeking AlphaWuXi Biologics: Eyes On Long-Term Risks And Near-Term Outlook (Rating Downgrade)
2024-10-04+0.0%M&ASeeking AlphaChinese biotechs gain as drugmakers targeted in new security bill said to mull divestments
2026-04-24—newsPR NewswireWuXi Biologics Chengdu Microbial Commercial Manufacturing Site Achieves Structural Completion and Key Equipment Arrival
tickerdossier.comtickerdossier.substack.com